Table 9.
Within diagnoses, the percentage of all antibiotic prescriptions by antibiotic class
| Percentage of total prescriptions by body system/condition |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RT/ENT |
Skin and wounds |
Urogenital tract |
Other and unknown body system |
||||||||||||||
| ATC codec | GI tract | LRTI | URTI excl. sore throat | sore throat | cough | ear | other RTI | skin excl. acne | acne | urinary tract | genital tract | unspecific urogenitala | other body systemsb | misc. codes | multiple body systems | no (informative) read code | Overall |
| J01AA02 | 2.3 | 12.8 | 15.1 | 0.9 | 9.3 | 1.3 | 14.2 | 2.4 | 10.7 | 0.4 | 8.4 | 4.1 | 9.5 | 5.6 | 6.5 | 7.5 | 6.6 |
| J01AA06 | 0.5 | 0.5 | 0.4 | 0.1 | 0.4 | 0.1 | 0.6 | 1.1 | 14.9 | 0.0 | 0.3 | 0.1 | 0.8 | 0.8 | 1.1 | 3.5 | 1.7 |
| Other J01AA | 1.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.5 | 2.2 | 57.8 | 0.1 | 1.0 | 0.2 | 1.1 | 1.5 | 2.8 | 7.4 | 3.6 |
| J01CA | 22.7 | 61.4 | 62.1 | 17.1 | 66.0 | 69.0 | 53.3 | 3.6 | 0.2 | 6.4 | 6.2 | 5.3 | 29.4 | 23.3 | 29.4 | 18.0 | 27.5 |
| J01CE | 1.3 | 0.1 | 3.1 | 61.7 | 0.7 | 0.5 | 2.2 | 2.5 | 0.1 | 0.1 | 1.4 | 0.3 | 2.1 | 4.8 | 5.1 | 4.9 | 6.0 |
| J01CF | 1.9 | 0.1 | 0.3 | 0.1 | 0.1 | 5.5 | 1.6 | 61.4 | 1.9 | 0.3 | 8.8 | 1.7 | 21.9 | 17.0 | 12.0 | 8.2 | 11.1 |
| J01CR | 7.9 | 4.5 | 3.1 | 1.5 | 3.0 | 6.0 | 4.9 | 7.1 | 0.2 | 4.9 | 10.0 | 4.8 | 10.4 | 9.1 | 5.8 | 5.2 | 5.2 |
| J01DB | 4.0 | 0.8 | 0.7 | 0.6 | 0.8 | 0.7 | 1.0 | 0.8 | 0.0 | 6.3 | 2.3 | 4.7 | 1.3 | 3.4 | 2.4 | 4.4 | 2.8 |
| J01EA | 4.1 | 0.3 | 0.2 | 0.1 | 0.3 | 0.5 | 0.9 | 0.6 | 1.9 | 50.0 | 4.8 | 44.2 | 2.0 | 9.0 | 12.5 | 12.0 | 10.8 |
| J01FA01 | 3.8 | 3.9 | 5.7 | 9.2 | 5.6 | 7.0 | 4.3 | 7.2 | 11.4 | 0.2 | 2.7 | 0.6 | 5.1 | 4.8 | 4.4 | 4.9 | 4.9 |
| J01FA09 | 15.5 | 13.6 | 8.4 | 8.1 | 12.5 | 7.0 | 13.2 | 7.8 | 0.6 | 0.2 | 2.0 | 0.6 | 5.6 | 6.8 | 7.3 | 5.6 | 7.0 |
| Other J01FA | 0.6 | 0.6 | 0.3 | 0.2 | 0.4 | 0.3 | 1.2 | 0.2 | 0.0 | 0.1 | 4.6 | 0.5 | 0.7 | 1.0 | 0.5 | 3.1 | 1.4 |
| J01MA | 10.1 | 0.9 | 0.3 | 0.1 | 0.6 | 1.3 | 1.1 | 0.7 | 0.0 | 4.1 | 7.2 | 10.0 | 1.3 | 3.2 | 2.0 | 2.8 | 2.2 |
| J01XD | 21.6 | 0.0 | 0.1 | 0.2 | 0.0 | 0.2 | 0.2 | 1.6 | 0.1 | 0.3 | 38.5 | 3.2 | 7.1 | 4.3 | 2.1 | 2.3 | 2.1 |
| J01XE01d | 2.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.4 | 0.3 | 0.0 | 26.3 | 1.5 | 19.5 | 1.4 | 4.5 | 5.6 | 8.3 | 6.2 |
| Others | 0.7 | 0.3 | 0.0 | 0.0 | 0.1 | 0.3 | 0.4 | 0.5 | 0.2 | 0.3 | 0.3 | 0.2 | 0.3 | 0.9 | 0.5 | 1.9 | 0.9 |
| Total no. prescriptions | 40 510 | 297 246 | 211 025 | 24 2932 | 329 443 | 177 875 | 193 775 | 469 437 | 47 250 | 457 852 | 48 339 | 59 082 | 63 896 | 231 805 | 158 497 | 1 545 409 | 4 574 373 |
GI tract, gastrointestinal tract; LRTI, lower respiratory tract infection; URTI, upper respiratory tract infection.
Unspecific urogenital: conditions where urinary and genital tract could not be distinguished.
Other body systems: includes but is not limited to cardiovascular, dental and prophylactic use.
J01AA02, doxycycline; J01AA06: oxytetracycline; other J01AA, other tetracyclines; J01CA, extended-spectrum penicillins; J01CE, β-lactamase-sensitive penicillins; J01CF, β-lactamase-resistant penicillins; J01CR, combinations of penicillins; J01DB, cephalosporins (1st generation); J01EA, trimethoprim and derivatives; J01FA01, erythromycin; J01FA09, clarithromycin; other J01FA, other macrolides; J01MA, fluoroquinolones; J01XD, imidazole derivatives; J01XE01, nitrofurantoin.
Unlike in other analyses, nitrofurantoin prescriptions were here not automatically assumed to be for UTI.